| Name | Title | Contact Details |
|---|---|---|
Geoff Nichol |
CMO and SVP, Global Clinical Development | Profile |
Jennifer Bzura-Lanzafame |
Senior Director, Center of Operational Excellence - World Wide R&D | Profile |
Mantej Chhina |
Head, Global R&D and Regulatory Policy | Profile |
Kendra Bolt |
Chief of Staff to the President of Worldwide Research & Development | Profile |
Kevin Eggan |
Head of Research and Early Development | Profile |
STIMIT`s proprietary technology enables extended local delivery of cancer immunotherapy in the context of tumor resection, the standard of care for most patients with solid tumors. Concentrating and retaining the action of potent immunomodulators locally dramatically improves the efficacy and safety of these compounds relative to administration in solution, whether via intravenous or even intratumoral injection.
Micropoint Bioscience is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cyagra Inc is a Elizabethtown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.
Dewpoint Therapeutics is leveraging a transformative shift in the understanding of cellular biology regulation to discover and advance breakthrough small-molecule therapeutics.